Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Aramark
High uncertainty: The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-77.1% vs price
Base Case (Median)
-64.7% vs price
Bull Case (75th pct.)
-49.9% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $0.56 | -99.0% | High (40%) |
| PE Comparable | $26.95 | -51.5% | Medium (25%) |
| Growth Trajectory DCF | $43.82 | -21.1% | Medium (20%) |
| Graham Number | $19.60 | -64.7% | Medium (30%) |
| EV/EBITDA | $28.70 | -48.3% | Medium (20%) |
| EV/FCF | $13.33 | -76.0% | Medium (20%) |
| Earnings Power Value | $12.07 | -78.3% | Medium (50%) |
Based on 7 out of 7 methods, ARMK appears overvalued at the current price of $55.55. The base case fair value of $19.60 implies 64.7% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.